We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+12.88%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$25.5B
AUM Growth
+$295M
(+1.2%)
Cap. Flow
-$1.85B
Cap. Flow
% of AUM
-7.26%
Top 10 Holdings %
Top 10 Hldgs %
26.12%
Holding
1,192
New
132
Increased
326
Reduced
512
Closed
172
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$287M |
| 2 |
GE Vernova
GEV
|
+$191M |
| 3 |
Monster Beverage
MNST
|
+$177M |
| 4 |
Fortinet
FTNT
|
+$176M |
| 5 |
General Motors
GM
|
+$164M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palo Alto Networks
PANW
|
+$308M |
| 2 |
Microsoft
MSFT
|
+$208M |
| 3 |
Lam Research
LRCX
|
+$198M |
| 4 |
Apple
AAPL
|
+$194M |
| 5 |
Spotify
SPOT
|
+$166M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.58% |
| 2 | Industrials | 13.29% |
| 3 | Financials | 13.04% |
| 4 | Consumer Discretionary | 12.82% |
| 5 | Healthcare | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LINE
951
Lineage Inc
LINE
$9.43B
| $267K | ﹤0.01% |
+6,140
| New | +$296K |
|
952
BioLife Solutions
BLFS
$1.46B
| $267K | ﹤0.01% |
12,394
| – | – |
|
953
Levi Strauss
LEVI
$9.44B
| $266K | ﹤0.01% |
14,391
| – | – |
|
|
IMA
954
ImageneBio Inc
IMA
$63.1M
| $265K | ﹤0.01% |
16,509
-3,948
| -19% | -$58K |
|
|
MRC
955
DELISTED
MRC Global
MRC
| $261K | ﹤0.01% |
19,029
| – | – |
|
956
Personalis
PSNL
$1.26B
| $260K | ﹤0.01% |
39,629
-327,333
| -89% | -$1.52M |
|
957
Sinclair Inc
SBGI
$974M
| $260K | ﹤0.01% |
+18,806
| New | +$267K |
|
958
CSP Inc
CSPI
$80.1M
| $259K | ﹤0.01% |
+20,006
| New | +$288K |
|
959
Forrester Research
FORR
$172M
| $256K | ﹤0.01% |
25,872
+9,742
| +60% | +$96.9K |
|
|
AMWD
960
DELISTED
American Woodmark
AMWD
| $254K | ﹤0.01% |
+4,766
| New | +$269K |
|
961
Cable One
CABO
$213M
| $253K | ﹤0.01% |
+1,866
| New | +$350K |
|
|
GNTY
962
DELISTED
Guaranty Bancshares
GNTY
| $251K | ﹤0.01% |
5,905
-19,268
| -77% | -$780K |
|
963
Mativ Holdings
MATV
$448M
| $243K | ﹤0.01% |
+35,600
| New | +$205K |
|
964
OP Bancorp
OPBK
$233M
| $241K | ﹤0.01% |
+18,527
| New | +$226K |
|
965
USCB Financial Holdings
USCB
$396M
| $239K | ﹤0.01% |
14,479
-14,600
| -50% | -$245K |
|
966
Cardlytics
CDLX
$21M
| $239K | ﹤0.01% |
14,548
-56
| -0.4% | -$967 |
|
967
Limoneira
LMNR
$237M
| $226K | ﹤0.01% |
14,436
| – | – |
|
968
Cato Corp
CATO
$65.9M
| $225K | ﹤0.01% |
79,979
+27,714
| +53% | +$73.7K |
|
969
Howmet Aerospace
HWM
$116B
| $224K | ﹤0.01% |
+1,206
| New | +$186K |
|
970
Bankwell Financial Group
BWFG
$496M
| $224K | ﹤0.01% |
+6,207
| New | +$206K |
|
971
Theravance Biopharma
TBPH
$874M
| $223K | ﹤0.01% |
20,174
-141,623
| -88% | -$1.38M |
|
972
PTC Therapeutics
PTCT
$6.37B
| $222K | ﹤0.01% |
4,542
-31,527
| -87% | -$1.5M |
|
|
MITT
973
TPG Mortgage Investment Trust
MITT
$230M
| $221K | ﹤0.01% |
+29,279
| New | +$203K |
|
974
Syndax Pharmaceuticals
SNDX
$1.84B
| $220K | ﹤0.01% |
+23,530
| New | +$259K |
|
975
Altria Group
MO
$122B
| $220K | ﹤0.01% |
3,747
-74,299
| -95% | -$4.36M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2025 Portfolio in Review
As of Q2 2025, Jacobs Levy Equity Management held 1,192 positions worth $25.5B, up 1.2% from $25.2B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jacobs Levy Equity Management withdrew a net $1.85B in Q2 2025, closing 172 positions and reducing 512 holdings. Its most notable exit was DuPont de Nemours, an estimated $72.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Industrials and Financials.
Against the trend, Jacobs Levy Equity Management opened a new position in Fastenal worth $83.5M.
- Jacobs Levy Equity Management's largest Q2 2025 buy was Fastenal: 1,987,617 shares worth $83.5M.
- Jacobs Levy Equity Management added most to Qualcomm in Q2 2025, an estimated $287M increase.
- Jacobs Levy Equity Management's biggest Q2 2025 reduction was Palo Alto Networks, cutting an estimated $308M.
- Jacobs Levy Equity Management fully exited DuPont de Nemours in Q2 2025, selling an estimated $72.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 26% of its $25.5B portfolio in Q2 2025.
- Jacobs Levy Equity Management opened 132 new positions and closed 172 in Q2 2025.
- Jacobs Levy Equity Management's portfolio value rose 1.2% quarter-over-quarter to $25.5B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2025, filed 14 Aug 2025.